Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.

Kemmner, Stephan; Guba, Markus O; Schönermarck, Ulf; Stangl, Manfred; Fischereder, Michael

Kemmner, Stephan; Guba, Markus O; Schönermarck, Ulf; Stangl, Manfred; Fischereder, Michael.

Kemmner S; Transplant Center, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany. Electronic address: stephan.kemmner@med.uni-muenchen.de.
Guba MO; Department of General, Visceral, and Transplant Surgery, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Schönermarck U; Renal Division, Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Stangl M; Department of General, Visceral, and Transplant Surgery, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Fischereder M; Renal Division, Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.

Kidney Int ; 98(2): 507-508, 2020 08.

Article in English | MEDLINE | ID: covidwho-526802

Subject(s)

Coronavirus Infections; Kidney Transplantation; Pandemics; Pneumonia, Viral; Pneumonia; Severe Acute Respiratory Syndrome; Betacoronavirus; COVID-19; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / Pneumonia, Viral / Kidney Transplantation / Coronavirus Infections / Severe Acute Respiratory Syndrome / Pandemics Limits: Humans Language: English Journal: Kidney Int Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google